Provided by Tiger Trade Technology Pte. Ltd.

Personalis

16.00
-0.0600-0.37%
Post-market: 16.000.00000.00%19:54 EDT
Volume:1.84M
Turnover:29.52M
Market Cap:1.71B
PE:-14.58
High:16.24
Open:16.19
Low:15.98
Close:16.06
52wk High:18.89
52wk Low:4.96
Shares:107.00M
Float Shares:72.63M
Volume Ratio:0.67
T/O Rate:2.53%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0976
EPS(LYR):-0.9107
ROE:-50.32%
ROA:-25.03%
PB:7.28
PE(LYR):-17.57

Loading ...

Personalis blood collection kits win EU CE-IVD mark under IVDR

Reuters
·
Jun 09

Can Personalis (PSNL) Turn NeXT Personal’s Multi‑Tumor MRD Data Into Durable Competitive Advantage?

Simply Wall St.
·
Jun 08

Personalis CFO, COO Aaron Tachibana disposes of common shares worth $480,400

Reuters
·
Jun 06

Personalis' Cancer Monitoring Tool Shows Early Detection of Relapse

MT Newswires Live
·
Jun 02

Personalis NeXT Personal MRD test posts 100% sensitivity for colorectal cancer relapse in VICTORI study at ASCO 2026

Reuters
·
Jun 02

Personalis CEO Christopher M. Hall disposes of common shares worth $1,101,800.18

Reuters
·
May 30

Personalis CFO, COO Aaron Tachibana disposes of common shares valued at $449,248.42

Reuters
·
May 30

Personalis NeXT Personal ctDNA assay posts 100% longitudinal sensitivity for colorectal cancer recurrence in VICTORI study

Reuters
·
May 26

Analysts Are Bullish on These Healthcare Stocks: Personalis (PSNL), Eton Pharmaceuticals (ETON)

TIPRANKS
·
May 22

Personalis Inc - CMS Expands Medicare Coverage for Personalis Next Personal Test in Breast Cancer Monitoring - SEC Filing

THOMSON REUTERS
·
May 21

Analysts Are Bullish on These Healthcare Stocks: Insmed (INSM), Personalis (PSNL)

TIPRANKS
·
May 20

Personalis NeXT Disease Test Approved for Expanded Coverage by Medicare, Medicaid

MT Newswires Live
·
May 20

Personalis secures fourth Medicare coverage decision for NeXT Personal

TIPRANKS
·
May 20

Personalis cites PREDICT-DNA study supporting NeXT Personal monitoring in breast cancer NAT

Reuters
·
May 20

Personalis Secures Fourth Medicare Coverage Decision for Next Personal®, Expanding Breast Cancer Coverage to Pre-Surgical Treatment Monitoring

THOMSON REUTERS
·
May 20

Personalis Inc - Coverage NOW Includes Neoadjuvant Therapy Monitoring for Stage Ii-Iii Tnbc or Her2+ Breast Cancer

THOMSON REUTERS
·
May 20

Personalis Shareholders Back Directors, Auditor and Executive Pay

TIPRANKS
·
May 14

Personalis Gains Expanded Medicare Coverage for NeXT Personal

TIPRANKS
·
May 14

Personalis stockholders elect two Class I directors at annual meeting

Reuters
·
May 14

Sector Update: Healthcare Stocks Lean Lower Pre-Bell Wednesday

MT Newswires Live
·
May 13